Dr. Khandelwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML7015
Cincinnati, OH 45229Phone+1 513-636-4266Fax+1 513-636-3549
Summary
- Dr. Pooja Khandelwal is a pediatric hematologist/oncologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. She received her medical degree from Kasturba Medical College Manipal and has been in practice 12 years. She is experienced in hematopoietic stem cell transplantation and transplantation conditioning. She has more than 40 publications and over 500 citings.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2010 - 2013
University of Arizona College of Medicine-TucsonResidency, Pediatrics, 2007 - 2010
Kasturba Medical College ManipalClass of 2005
Certifications & Licensure
OH State Medical License 2010 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Use of Bortezomib to Treat Refractory Autoimmune Cytopenia(s) in Allogeneic Stem Cell Transplantation Start of enrollment: 2012 Jul 01
- Maraviroc as GVHD Prophylaxis in Transplant Recipients Start of enrollment: 2014 Jul 01
- Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients Start of enrollment: 2020 Aug 26
- Join now to see all
Publications & Presentations
PubMed
- Chronic graft-versus-host disease adversely impacts school performance in children and young adults.Zahra Hudda, Amanda Flannery, Patricia Dillhoff, Kristen Webster, Jodi Jacobs
Transplantation and Cellular Therapy. 2024-12-13 - 2 citationsRuxolitinib Pharmacokinetics and Pharmacodynamics in Children with Acute and Chronic Graft-versus-Host Disease.Eleanor Cook, Min Dong, Samuel C C Chiang, David Luedeke, Kelly E Lake
Transplantation and Cellular Therapy. 2024-05-01 - 2 citationsUse of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults.Kristie N Ramos, Daniel Leino, Nathan Luebbering, Michael S Grimley, Priscila Badia
Transplantation and Cellular Therapy. 2024-04-01
Press Mentions
Can Human Breast Milk Reduce Intestinal Injury Following Bone Marrow Transplant?April 5th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
